Sandra Cuellar, PharmD, BCOP, discusses challenges with data extrapolation for biosimilars.
Sandra Cuellar, PharmD, BCOP
Advertisement
Articles by Sandra Cuellar, PharmD, BCOP
Sandra Cuellar, PharmD, BCOP, discusses the pharmacoeconomic benefits of biosimilars.
Advertisement
Latest Updated Articles
Dr. Cuellar on the Pharmacoeconomic Benefits of BiosimilarsPublished: April 30th 2020 | Updated:
Dr. Cuellar on Concerns With Extrapolating Data for BiosimilarsPublished: August 19th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5